Expert Pitch

Political scientist: López Obrador may be more pragmatic than expected

Indiana University
3-Jul-2018 12:05 PM EDT, by Indiana University

Andres Manuel López Obrador won Mexico's July 1 presidential election by repeating the successful formula of other populist candidates in Latin America, said Armando Razo, associate professor of political science at Indiana University Bloomington. He ran as an outsider amidst deep mistrust of establishment politicians, and his campaign resonated with a discontented citizenry, which demanded major changes to address Mexico's severe economic and political problems, especially rampant insecurity and political violence in recent years.

But the big question is how López Obrador will actually govern after he gets inaugurated on Dec. 1, said Razo, who is available by email to answer news media questions about the election.

"It's too early to say, but current signs indicate that he might be less radical than expected from his campaign pronouncements -- to the relief of his detractors and potential disillusionment from core supporters," he said.

"He won't be tempted to bypass institutional checks as other populist governments in the region have done for a couple of reasons. In an election that only requires a plurality to win, he received more than 50 percent of the vote, an unprecedented popular mandate. And, most importantly, López Obrador's party is also likely to control the bicameral Congress, so he will face a more favorable institutional environment than his predecessors who had to govern under more divided government."

López Obrador's contentious exchanges with business actors during the campaign produced worries about potentially drastic changes in economic policy. But "economic worries were somewhat mitigated when López Obrador adopted a more conciliatory tone towards business right before the election, which he and his advisors have reiterated this week to reassure investors that there won't be drastic economic changes," Razo said.

In terms of foreign policy, Razo said, populism in Latin America has typically carried an anti-American sentiment, but proximity to the U.S. and dependence of foreign trade and migrant remittances warrant a more pragmatic approach from López Obrador, as opposed to the more antagonistic stance of leaders like the former president of Venezuela, Hugo Chavez.

"But we won't know for a while how U.S.-Mexico relations will proceed because several critical issues like NAFTA renegotiations have been put on hold until after U.S. midterm elections," he said.

To reach Razo, contact Steve Hinnefeld at 812-856-3488 or slhinnef@iu.edu.




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
1.2812